When we analyzed the DCIS group, we found that factors belonging to Group 1 (TNFα & IL-1β) "tended" to be expressed in the same biopsies in which the factors of group 2 were expressed (CCL2 & CCL5) (Figure 3a). Here, CCL5 is linked to ductal breast carcinoma in situ.